LeonaBio, Inc.
LONA · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 4 ·
Latest disclosures
-
Perceptive Advisors Llc: Form 4
Insider disclosure · Filed · Report period 26 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001620463 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- LONA on Nasdaq
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 18706 North Creek Parkway, Suite 104, Bothell, WA, 98011
- Fiscal year end
- 31 December
- Former names on EDGAR
- Athira Pharma, Inc. (to 08 Jan 2026), M3 Biotechnology, Inc. (to 23 Jan 2019)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields